Copy and paste this code to insert a reference to this article in your
blog or online community profile:
<div style="margin:10px 10px 10px 10px; padding-left:10px;text-align:left; border-left:10px solid #990033;"> <span style="font-size:14px; padding-bottom:5px; font-weight:bold;">A Commentary on: Immunogenicity and Safety of a Recombinant COVID-19 Vaccine as Heterologous Booster After Priming with Inactivated Vaccine in Healthy Children and Adolescents Aged 3-17 Years: An Open-labeled, Single-arm Clinical Trial</span><br/> <span>J Infect Dis Ther. 12:4, (2024)<br/> https://doi.org/10.4172/2332-0877.1000597</span> </div>
Highlight
Will Display Like this:
A Commentary on: Immunogenicity and Safety of a Recombinant COVID-19 Vaccine as Heterologous Booster After Priming with Inactivated Vaccine in Healthy Children and Adolescents Aged 3-17 Years: An Open-labeled, Single-arm Clinical Trial
J Infect Dis Ther. 12:4, (2024)
https://doi.org/10.4172/2332-0877.1000597
Powered by
OMICS International